Please assess the completion status of the following clinical trial:

Trial Title: Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a depressive episode~* HDRS score \> 18~* Written informed consent~Exclusion Criteria:~* suicidal risk \> 3~* severe organic illness~* other psychotropic drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Citalopram + placebo (Type: PLACEBO_COMPARATOR): Citalopram 20 mg/day t.i.d
- Citalopram + pindolol (Type: EXPERIMENTAL): Citalopram 20 mg/day t.i.d Pindolol 15 mg/day t.i.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).